Board of Directors (from left to right): William B. Harrison, Jr., 61, chairman and chief executive officer, J.P. Morgan Chase & Co.; (seated) Anne M. Tatlock, 65, chairman and chief executive officer, Fiduciary Trust Company International; Wendell P. Weeks, 45, president and chief operating officer, Corning Incorporated; (seated) William G. Bowen, Ph.D., 71, president, The Andrew W. Mellon Foundation; William N. Kelley, M.D., 65, professor of Medicine, Biochemistry and Biophysics, University of Pennsylvania School of Medicine; Raymond V. Gilmartin, 64, chairman, president and chief executive officer; Peter C. Wendell, 54, managing director, Sierra Ventures; (seated) Thomas E. Shenk, Ph.D., 58, Elkins professor, Department of Molecular Biology, Princeton University; (seated) Lawrence A. Bossidy, 70, retired chairman and chief executive officer, Honeywell International Inc.; Johnnetta B. Cole, Ph.D., 68, president, Bennett College for Women; Samuel O. Thier, M.D., 67, professor of Medicine and professor of Health Care Policy, Harvard Medical School; Rochelle B. Lazarus, 57, chairman and chief executive officer, Ogilvy & Mather Worldwide.

Merck's Board of Directors elected a new member this past year. Rochelle B. Lazarus, chairman and chief executive officer of Ogilvy & Mather Worldwide, a leading advertising and marketing communications company, became a director in October 2004.